Needle Protection Assembly

ABSTRACT

The application relates to a needle protection assembly ( 1 ) comprising:—a supporting element ( 18 ) and a needle shield ( 8 ),—one locking element ( 20 ) located within said needle protection assembly ( 1 ) and not accessible to the user,—urging means ( 24 ) for displacing said needle shield ( 8 ),—a peg ( 19 ) located on said supporting element ( 18 ) or on said needle shield ( 8 ), and a cam ( 9 ) located on said needle shield ( 8 ) or on said supporting element ( 18 ), and—said locking element ( 20 ) is not formed by said peg ( 19 ) and cam ( 9 ). The respective longitudinal axis of the needle shield ( 8 ) and of the locking element ( 20 ) are merged when said needle shield ( 8 ) is in its before use or in use positions, and they form an angle (a) when said needle shield ( 8 ) is in its after use position.

CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application of U.S. patentapplication Ser. No. 12/988,366 entitled “Needle Protection Assembly”filed Mar. 28, 2011, which is a U.S. national stage entry ofInternational Application No. PCT/IB2009/005523, filed Apr. 14, 2009,the entire disclosures of each of which are hereby incorporated byreference.

The present invention relates to a needle protection assembly that is tobe connected to an injection device such as a syringe in view ofcompleting an injection, said needle protection assembly being triggeredafter the injection in order to protect the user from accidental needlestick injuries and prevent needle re-use.

In this application, the “distal end” of a component or of a device isto be understood as meaning the end furthest from the user's hand andthe “proximal end” is to be understood as meaning the end closest to theuser's hand. Likewise, in this application, the “distal direction” is tobe understood as meaning the direction of injection, and the “proximaldirection” is to be understood as meaning the opposite direction to thedirection of injection.

In the medical field, it is usual to provide injection devices withneedle protection systems in order to prevent the needle to be reachedby the user or the patient before and/or after use of the injectiondevice, in view of limiting accidental needle stick injuries. inaddition, such needle protection systems also enable to prevent re-useof the injection devices.

Usually, the needle protection systems include a needle shield able tomove distally over the needle once the injection is completed. Thedistal movement of the needle shield with respect to the needle is oftentriggered by a spring in an automatic way when the needle is withdrawnfrom the injection site. In general, the needle shield is then locked inits “after use” position thanks to a locking system, most of the timebased on the cooperation of deflecting members located either on theneedle hub and/or on the needle shield.

The document US2005/0113750 discloses such a needle protection system inwhich the locking system comprises a spring urging a needle shieldtoward its “after use” position and a deflecting leg provided on theneedle shield, the deflecting leg being engaged into a groove providedon the needle hub in the “after use” position. US2003/0014018 alsodiscloses a needle protection system in which the locking systemcomprises a spring urging a needle shield toward its “after use”position and deflecting legs;

Nevertheless, the needle protection systems of the prior art have thedrawback that, because of the energy necessary to deflect the deflectingmembers, the spring force must be high in order to displace the needleshield and overcome the deflecting members resistance. This has theconsequence that, in storage position, before use, the high spring forceof the compressed spring may deform the usual plastic parts forming theneedle assembly and/or the injection device. This deformation may causethe needle protection system not to work properly at the time of use.This deformation may also cause wrong depth injection at the time of theinjection. Indeed, during the injection, the high spring force will pushthe needle shield against the, skin, generating a push back force on theinjection device proportional with the high force of the spring. Thispush back force will render difficult and unpredictable the accuratepositioning of a constant pressure on the skin and make the injectionoperation more difficult to perform. In addition, springs with highforce are more cumbersome, expensive and difficult to assemble than lowduty spring. On the other side, low duty springs do not apply enoughforce to be able to overcome the deflecting members resistance and allowthe needle protection system to work properly.

WO2005/044349 discloses a needle protection system in which the lockingsystem comprises a spring urging a needle shield toward its “after use”position and an arm provided with a pin, the pin having to overcome ablocking element before coming engaged into a groove provided on theneedle hub in the “after use” position. Once again, the device ofWO2005/044349 requires a spring with a high force in order for the pinto overcome the resistance of the blocking element.

EP 1 447 108 discloses a needle protection system in which the lockingsystem comprises cantilever arms.

US2005/0277893 discloses a needle shield that becomes misaligned withthe needle hub in its “after use” position. Nevertheless, in the deviceof US2005/0277893, the needle is not guided between a “before use”position and the “in use” position and in the case where the needle isflexible, it is difficult to perform a safe and controlled injection. Inaddition, in US2005/0277893, the needle is not visible in the “beforeuse” position of the device. It is therefore difficult for a user todetermine whether the device is in its “before use” position or in its“after use” position and when the “in use” position is reached.

Moreover, the needle protection systems of the prior art necessitate aplurality of different parts, in particular several parts forming thelocking system, and the needle protection systems are thereforedifficult and long to manufacture.

There is therefore a need for a needle protection assembly that would beeasily triggered at the end of the injection in order to avoidaccidental needle stick for the user and prevent the re-use of theneedle. There is at the same time a need for a needle protectionassembly that would not be likely to cause the deformation of theplastic parts forming the needle protection assembly during storage,that would be easy to assemble, and that would be user friendly. Inaddition, there is a need for a needle protection assembly that allowsthe needle to be visible and to be guided, for example from a “beforeuse” position in which only a part of the needle is visible, and an “inuse” position in which the needle is uncovered on its usable length forthe injection.

The present invention remedies to this problem by providing a needleprotection assembly comprising both a specific locking system so thatthe urging means, such as a spring, used to cause the distal movement ofthe protection at the end of the injection is a low duty urging meansthat does not need to show a too high force, and a specific positioningsystem allowing the needle to be visible before use, and to be guidable,for example from the “before use” position to the “in use” position, sothat it is easy for the user to operate the system between the “beforeuse”, “in use” and the “after use” positions.

A first aspect of the invention is a needle protection assembly intendedto protect the needle of a needle assembly, said needle protectionassembly comprising at least a supporting element and a needle shield,said needle shield being axially movable with respect to said supportingelement between an “in use” position in which said needle shield isintended to leave an “in use” portion of said needle uncovered, and an“after use” position distally spaced apart from said “in use position”and in which said needle shield is intended to cover said needle,

said needle protection assembly further comprising:

at least one locking element located within said needle protectionassembly and not accessible to the user, said locking element beingmovable between at least a “free” position, in Which said needle shieldcan be moved at least from its “in use” position to its “after use”position, and a “locking” position in which said locking elementprevents said needle shield from moving back from its “after use”position in the proximal direction,

urging means intended to displace said needle shield from its “in use”position to its “after use” position,

a peg located on said supporting element or on said needle shield, and acam located respectively on said needle shield or on said supportingelement, said peg being movable within said cam so as to define said “inuse” and “after use” positions, upon increased or released distalpressure exerted by the user on said needle protection assembly, and

said locking element being not formed by said peg and said cam,

characterized in that

said needle shield having a longitudinal axis (A; A′), said lockingelement has a general longitudinal shape having a longitudinal axis (B;B′), the longitudinal axis (A; A′) of the needle shield and thelongitudinal axis (B, B′) of the locking element are merged when saidneedle shield is in its “in use” positions, said longitudinal axis (A;A′) of the needle shield forms an angle (α; α′) with the longitudinalaxis (B; B′) of the locking element when said needle shield is in its“after use” position.

In the present application, by “merged” is meant that the longitudinalaxis A, respectively A′, and B, respectively B′, are coaxial, they areidentical.

In the present application, by “form an angle” is meant that thelongitudinal axis A, respectively A′, and B, respectively B′, are nomore coaxial, they intersect and form an angle which is different than0°, 180°or 360°.

In an embodiment of the invention, said needle shield is axially movablebetween a “before use” position, in which said needle shield leaves a“before use” portion of the needle uncovered, said “in use” portionbeing greater than said “before use” portion, and said “in use”position. The peg and cam may also define the “before use” position.

In the needle protection assembly of the invention, the urging means,for example a spring, is used to cause The movement of the needle shieldonce the injection is completed but it does not have to overcome thefriction force opposed by deflecting members of the locking systems ofthe prior art or any point of resistance to lock the needle shield inits “after use” position. It is the fact that the needle shield and thelocking element are displaced one with respect to the other, forexample, they are no more coaxial and form an angle, in the “after use”position of the needle shield, that locks the needle shield in said“after use” position. Less force is required from the urging means, suchas the spring, of the needle protection assembly of the invention. Inconsequence, the urging means of the assembly of the invention, even inthe “storage” position or in the “before use” position, does not exert ahigh force on the plastic parts forming the assembly. The risks ofdeformation of these plastic parts are therefore limited with the needleprotection assembly of the invention. In addition, a weaker spring thanthe springs used in the devices of the prior art may be used as urgingmeans in the needle protection assembly of the invention.

The needle protection assembly of the invention is therefore easier tomanufacture than assemblies of the prior art. The needle protectionassembly of the invention, because it requires less manufacturing parts,is also environment friendly.

The needle protection assembly of the invention allows the needle to bevisible in the “before use” position of the assembly. Moreover, theneedle is guided from the “before use” position to the “in use”position: the needle is therefore rendered more rigid during this stepand the injection is safer. The needle protection assembly is thereforeof easier use for the user who can see the needle and who can easilydetermine where to prick. Moreover, the needle protection assembly ofthe invention is provided with a positioning system allowing the user toknow when the needle protection assembly is in its “before use”position, in its “in use” position and in its “after use” position.

Moreover, the locking element of the needle protection assembly of theinvention is not accessible for the user. The user can therefore not putthe needle shield back in its “in use” position once said needle shieldhas reached its “after use” position. The needle protection assembly ofthe invention is therefore particularly safe.

In an embodiment of the invention, said cam includes at least a firstand a second longitudinal tracks, both having a globally longitudinalshape and joining at an intersection via their respective proximal ends,respectively via their respective distal ends, said peg being located atan “initial” position in said first track when said needle shield is inits “before use” position, and said peg being located at a “final”position in said second longitudinal track or beyond said secondlongitudinal track, when said needle shield is in said “after use”position, said “final” position of the peg being distally, respectivelyproximally, spaced with respect to said “initial” position.

Said peg may be located at said intersection of the first and secondlongitudinal tracks when said needle shield is in its “in use” position.

In an embodiment of the invention, said cam is provided with an inclinedsurface at the vicinity of the intersection of said first and secondlongitudinal tracks, said inclined surface urging said peg in the secondlongitudinal track when said needle shield moves from its “in use”position to its “after use” position.

In an embodiment of the invention, said supporting element is an outersleeve receiving both said needle shield and said locking element.

In an embodiment of the invention, said supporting element forms atleast part of said locking element.

Said locking element may have the global shape of a tube provided at itsproximal end with an asymmetrical outer flange. Preferably, said outerflange is provided with a proximal inclined surface. Said outer flangemay be provided with one projection extending proximally.

In an embodiment of the invention, said urging means comprise at least ahelical spring.

Another aspect of the invention is a needle assembly comprising at leasta needle hub provided with a needle wherein it further comprises aneedle protection assembly as described above. Said supporting elementmay comprise said needle hub.

Another aspect of the invention is an injection device comprising atleast a needle assembly and a reservoir, wherein it further comprises aneedle protection assembly as described above.

The needle protection assembly of the invention will now be furtherdescribed in reference to the following description and attacheddrawings in which:

FIG. 1 is a partial cross section view of an injection device comprisinga needle protection assembly according to the invention, in the “beforeuse” position,

FIG. 2 is a perspective view of the needle shield of the needleprotection assembly of FIG. 1,

FIG. 3 is a side view of the locking element of the needle protectionassembly of FIG. 1,

FIG. 4 is a partial cross section view of the injection device of FIG. 1in the “in use” position,

FIG. 5 is a partial cross section view of the injection device of FIG. 1when the needle shield reaches its “after use” position,

FIG. 6 is a partial cross section of the injection device of FIG. 1 whenthe needle shield is locked in its “after use” position.

FIGS. 7 to 9 are partial views of the needle protection assembly of theinjection device of FIGS. 1-6 showing the peg position in the cam,respectively in the following positions: “before use”, “in use” and“after use”,

FIG. 10 is a side view of an alternative embodiment of a locking elementof a needle protection assembly of the invention,

FIG. 11 is a partial cross section view of the injection device of FIG.1-6 showing assembly of the locking element and urging means,

FIG. 12 is a partial cross section view of an injection devicecomprising an alternative embodiment of a needle protection assemblyaccording to the invention, in the “before use” position,

FIG. 13 is a perspective view of the locking element of the needleprotection assembly of FIG. 12,

FIG. 14 is a partial cross section view of the injection device of FIG.12 in the “in use” position of the needle shield.

FIG. 15 is a partial cross section view of the injection device of FIG.12 when the needle shield reaches its “after use” position,

FIG. 16 is a partial cross section view of the device of FIG. 12 whenthe needle shield is locked in its “after use” position.

In the following description, the needle protection assembly of theinvention has at least two positions:

an “in use” position during which the injection device is appliedagainst the injection site, the user exerts a distal pressure on theinjection device, the needle is inserted in the injection site and isnot covered by the needle shield: in this “in use” position, the needleis uncovered by the needle shield on an “in use” portion correspondingto its usable length, that is to say its length necessary to penetratethe patient's kin to perform the injection at the right injection depth;

en “after use” position after withdrawal of the needle from theinjection site, in which the user does not exert any more any distalpressure on the injection device: in this “after use” position, theneedle shield covers the needle.

Preferably, the needle protection assembly of the invention has also a“before use” position, before proper use of the injection device bearingthe needle protection assembly of the invention; in this “before use”position the needle is at least partly uncovered by the needle shield ona “before use” portion, the “in use” portion in the “in use” positionbeing greater than the “before use” portion in the “before use”position, the needle being therefore visible in the “before use”position by the user who does not yet exert any distal pressure on theinjection device and who can properly adjust where the needle is to beinserted in the skin.

In reference to FIG. 1 is shown a needle protection assembly 1 accordingto the invention, in the “before use” position, mounted on an injectiondevice 100 (partially shown). The needle protection assembly 1 of theinvention comprises a support 2 that bears a needle 3. The support 2comprises an inner core 4, and a proximal part 5 of outer diameterlarger than the outer diameter of the inner core 4 and forming withrespect to said inner core 4 a rim 6. The rim 6 defines a distal planesurface 7 perpendicular to the longitudinal axis of the support 2.

The needle protection assembly 1 of FIG. 1 also comprises a needleshield 8 receiving at least partially said support 2 and in particularsaid inner core 4 of said support 2. With reference to FIG. 2, theneedle shield 8 has the global shape of a tube having a longitudinalaxis A. The needle shield 8 is open at its proximal end 8 a and at itsdistal end 8 b. The outer wall of the needle shield 8 is provided with acam 9. The cam 9 comprises a first longitudinal track 10 and a secondlongitudinal track 11 substantially parallel to each other and separatedby a separation wall 12. The first and second longitudinal tracks (10,11) are joined at their respective distal ends via an intersection 13.In the vicinity of the intersection 13, the first longitudinal track 10is provided with a ramp 14, the distal end of which is provided with aninclined surface 15, the inclined surface 15 facing the secondlongitudinal track 11. In addition, the first longitudinal track 10 isprovided with a step 16, located proximally with respect to said ramp14. The proximal end of the second longitudinal track 11 is providedwith a stop wall 17.

With reference to FIG. 1, the needle protection assembly 1 of FIG. 1further comprises a supporting element under the form of an .outersleeve 18 which receives the needle shield 8. The outer sleeve 18 isprovided in the distal region of its inner wall with at least a peg 19.

As will appear clearly from the description of FIGS. 1-6, the needleshield 8 is axially movable with respect to the outer sleeve 18 betweena “before use” position, in which said needle is uncovered by the needleshield 8 on a “before use” portion, the needle 3 being visible by theuser as shown on FIG. 1, an “in use” position in which said needleshield 8 leaves an “in use” portion of said needle 3 uncovered, the “inuse” portion being greater than the “before use” portion, as shown onFIG. 4, and an “after use” position in which said needle shield 8 coverssaid needle 3, as shown on FIG. 5.

The needle protection assembly 1 of FIG. 1 further comprises a tube 20surrounding the inner core 4 of the support 2, said tube 20 being partlyreceived within said needle shield 8. The tube 20 is also receivedwithin the supporting element or outer sleeve 18. With reference to FIG.3, the tube 20 has a longitudinal axis B and is open at its proximal end20 a and at its distal end 20 b. As appears on FIG. 3, a part of thewall of the tube 20 has been cut on a part of its length along alongitudinal plane, thereby defining a longitudinal cut 21 extendingfrom a point located distally with respect to the proximal end 20 a ofthe tube 20 up to the distal end 20 b of the tube 20. The tube 20 isprovided at its proximal end 20 a with an outer flange 22, said outerflange 22 being provided on its proximal face and substantially inalignment with the longitudinal cut 21 with one projection 23 extendingproximally. The outer flange 22 is therefore asymmetrical. On theexample shown, the projection 23 has a semi-spherical shape.

With reference to FIG. 1, in the “before use” position of the needleshield 8, the tube 20 is received within the needle shield 8 and theproximal face 20 a of the tube 20 bears on the distal plane surface 7defined by the rim 6 of the support 2 by means of the semi-sphericalprojection 23 of the outer flange 22 of the tube 20. As appears alsofrom FIG. 1, in this position, the tube 20 is maintained coaxial withthe needle shield 8 because it is surrounded by the needle shield 8which is tubular. In consequence, the respective longitudinal axis A andB of the needle shield 8 and of the tube 20 are merged but part of theproximal face of the outer flange 22 which is diametrically opposed tothe projection 23 does not contact the distal plane surface 7 of the rim6 as is shown on FIG. 1. As a remark, on this figure, the longitudinalaxis A and B are also merged with the longitudinal axis of the injectiondevice 100. In other words, the needle shield 8 and the tube 20 are inalignment with each other.

The needle protection assembly 1 of FIG. 1 further comprises a helicalspring 24, located between the needle shield 8 and the tube 20. On theexample shown on FIG. 1, the proximal end of the helical spring 24 bearson the distal face of the outer flange 22 of the tube 20 and its distalend bears on the proximal end of the needle shield 8. In the “beforeuse” position shown on FIG. 1, the helical spring 24 is in a partiallyexpanded state. As will appear later in the detailed description of theoperation of the injection device 100, the helical spring 24 acts asurging means for displacing the needle shield 8 from its “in use”position to its “after use” position.

The injection device 100 of FIG. 1 also comprises a barrel 25 (partiallyshown) intended to receive a product to be injected and said barrel 25being fixed to said outer sleeve 18 and to the support 2 bearing theneedle 3.

The operation of the needle protection assembly 1 and of the injectiondevice 100 will now be explained in reference to FIGS. 1 to 9.

On FIG. 1, the needle protection assembly 1 is in a “before use”position. In this “before use” position shown on FIG. 1, the needleshield 8 covers part of the needle 3. Therefore, the needle 3 is visiblefor the user. The user can prick the needle 3 in the site of injection

In this “before use” position shown on FIG. 1, as shown on FIG. 7, thepeg 19 of the outer sleeve 18 is in an initial position located betweenthe ramp 14 and the step 16 of the first track 10 of the cam 9 of theneedle shield 8. On FIGS. 7-9, for sake of clarity, only the peg 19 ofthe outer sleeve 18 is shown. One must understand that the peg 19 ispart of the outer sleeve 18 (not shown) which surrounds the needleshield 8, as shown on FIG. 1. The proximal movement of the peg 19 istherefore prevented by the step 16.

In this “before use” position shown on FIG. 1, the longitudinal axis Aof the needle shield 8 and the longitudinal axis B of the tube 20 aremerged, ie coaxial. The needle shield 8 and the tube 20 are in alignmentwith each other.

The user then applies the injection device 100 on the skin of a patient(not shown), inserts the needle 3 into the injection site until thedistal end 8 b of the needle shield 8 comes in contact with the skin. Inorder to fully insert the needle 3 in the site of injection, the userthen exerts a distal pressure on the injection device 100, this havingas a consequence to cause the distal movement of the outer sleeve 18with respect to the needle shield 8, as shown on FIG. 4, said needleshield 8 being blocked against the skin of the patient (not shown).During the distal movement of the outer sleeve 18, the support 2, whichis fixed to the outer sleeve 18, has also moved distally and has pushedthe tube 20 in the distal direction via the rim 6 contacting theprojection 23 of the outer flange 22 of the tube 20. The needle shield 8being stopped against the skin of the patient, the helical spring 24 isnow in a more compressed state than in the “before use” position, asshown on FIG. 4. As shown on FIG. 8, during the distal movement of theouter sleeve 18, the peg 19 has overcome the ramp 14 and is now inabutment against the proximal face of the intersection 13 of the firstand second longitudinal tracks (10, 11) of the cam 9. The needle shield8 is now in its “in use” position. The user may then realize theinjection of the product to be injected.

In this “in use” position of the needle shield 8 as shown on FIG. 4, thelongitudinal axis A of the needle shield 8 and the longitudinal axis Bof the tube 20 are merged. The needle shield 8 and the tube 20 are inalignment with each other.

Once the injection step (not shown) is completed, the user removes theinjection device 100 from the injection site and the needle shield 8 isno more blocked by the skin of the patient. The helical spring 24 istherefore free to return to its expanded state and it causes the distalmovement of the needle shield 8 with respect to the support 2 and to theouter sleeve 18 as shown on FIG. 5.

As shown on FIG. 9, the peg 19 of the outer sleeve 18 has been guidedinto the second longitudinal track 11 of the cam 9 by the inclinedsurface 15. The peg 19 has then travelled along the second longitudinaltrack 11 until it has reached the stop wall 17 at the proximal end ofsaid second longitudinal track 11 where said peg 19 reaches its finalposition, corresponding to the “after use” position of the needle shield8, as shown on FIG. 5. The final position of the peg 19 is thereforeproximally spaced with respect to its initial position.

The needle shield 8 therefore deploys and covers the needle 3, therebypreventing any accidental needle stick injury for the user and anyre-use of the injection device 100. During this step, the helical spring24 acts as urging means tending to displace the needle shield 8 from its“in use” position to its “after use” position.

While expanding, the helical spring 24 has pushed the needle shield 8distally beyond the tube 20 which is then no more surrounded by theneedle shield 8, as shown on FIG. 5, at the moment the needle shield 8reaches its “after use” position”. In consequence, the tube 20 is nomore maintained coaxial with the needle shield 8: thanks to thelongitudinal cut 21 and to the semi-spherical projection 23 rotating onitself, the tube 20 naturally cants, as shown on FIG. 6 and its distalend 20 b comes in regard to the proximal end 8 a of the needle shield 8.The tube 20 is no more coaxial with the needle shield 8. This can beseen on FIG. 6 on which the longitudinal axis A of the needle shield 8and the longitudinal axis B of the tube 20 intersect and are now formingan angle α. The tube 20 therefore acts as a locking element of theneedle shield 8 and is in a “locking position” when the needle shield 8is in its “after use” position. As is visible from FIGS. 1 and 4, inthe, “before use” and “in use” positions of the needle shield 8, thetube 20 remained coaxial with the needle shield 8 and did not preventmovement of said needle shield 8 from a position to the other. On theseFIGS. 1 and 4, the locking element formed by the tube 20 was in a “freeposition”. As appears clearly from the above description, the lockingelement, namely the tube 20, is in no way accessible to the user,whatever the position of the needle shield 8. The needle protectionassembly of the invention is therefore particularly safe.

In the needle protection assembly 1 and the injection device 100 of theinvention, the force of the helical spring 24 of the needle protectionassembly 1 and the injection device 100 of the invention does not needto be high because it does not have to overcome any flexible lockingmember. In consequence, when the needle protection assembly 1 and theinjection device 100 of the invention are in a “before use” position, asshown on FIG. 1, the force exerted by the spring 24 on the differentparts forming the needle protection assembly 1 and/or the injectiondevice 100 is not high and does not deform said parts. The spring 24 isnot cumbersome and the needle protection assembly 1 and/or the injectiondevice 100 can have moderate size. In addition, the spring 24 is easy toassemble because it requires less pressure to be compressed thane highforce spring.

Moreover, as appears from the description of FIGS. 1-9, the needle 3 isvisible in the “before use” position of the needle shield 8. The needle3 is also guided from the “before use” position of the needle shield 8to the “in use” position of the needle shield 8. The needle 3 istherefore protected during this step and it is rendered more rigid,therefore allowing a safe and controlled injection.

On FIG. 10 is shown an alternative embodiment of the tube 20 of FIG. 3.On FIG. 10, is shown a tube 32 which is provided with an asymmetricalouter flange 33, the proximal face 34 of which is inclined so that saidflange 33 is thicker in its part which is in alignment with alongitudinal cut 35 obtained as described for the longitudinal cut 21 ofthe tube 20 of FIG. 2. In consequence, in the “before use” and “in use”positions, the proximal face of the outer flange 33 is in contact withthe distal plane surface 7 of the rim 6 of the support 2 only by itsextremity located in alignment with the longitudinal cut 35. Once theneedle shield 8 is in its “after use” position and the tube 32 is nomore surrounded by the needle shield 8, the proximal face 34 of theouter flange 33 tends to come in tighter contact with the distal planesurface 7 of the rim 6 and the tube 32 cants as already described fortube 20 on FIGS. 1-9. The distal end 32 b of the tube 32 comes in regardto the proximal end 8 a of the needle shield 8 and the needle shield 8is locked in its “after use” position.

On FIG. 11 is shown the assembling of the tube 20 and the helical spring24 of the injection device 100 of embodiment of FIGS. 1-9. As can beseen on this figure, the tube 20 and the helical spring 24 can bepreassembled, thereby forming a subset that can then subsequently beassembled on the needle 3 via a lever 300. The injection device 100 istherefore very easy to manufacture.

On FIGS. 12-16 is shown an alternative embodiment of the needleprotection assembly of FIGS. 1-9 in which the cam is provided on thelocking element.

The references designating the same elements as in FIGS. 1-9 have beenmaintained.

In reference to FIG. 12 is shown a needle protection assembly 1according to the invention, in the “before use” position, mounted on aninjection device 100 (partially shown). The needle protection assembly 1of the invention comprises a support 2 that bears a needle 3. Thesupport 2 comprises an inner core 4, and a proximal part 5 of outerdiameter larger than the outer diameter of the inner cord 4 and formingwith respect to said inner core 4 a rim 6. The rim 6 defines a planesurface 7 perpendicular to the longitudinal axis of the support 2. Thesupport 2 is fixed to a barrel 25 intended to receive a product to beinjected.

The needle protection assembly 1 of FIG. 12 also comprises a needleshield 36 receiving at least partially said support 2 and in particularsaid inner core 4 of said support 2. The needle shield 36 has the globalshape of a tube having a longitudinal axis A′. The needle shield 36 isopen at its proximal end 36 a and at its distal end 36 b. The inner wallof the needle shield 36 is provided with at least one peg 37 projectinginwardly and radially.

The needle protection assembly 1 of FIG. 1 further comprises asupporting element under the form of a tube 38 surrounding the innercore 4 of the support 2, said tube 38 being partly received within saidneedle shield 36. With reference to FIG. 13, the tube 38 has alongitudinal axis B′ and is open at its proximal end 38 a and at itsdistal end 38 b. As appears on FIG. 13, a part of the wall of the tube38 has been cut along a longitudinal plane, thereby defining an openlongitudinal cut 39. As for tube 20 described on FIG. 2, thelongitudinal cut 39 extends from a point 39 a (visible on FIG. 12)located distally with respect to the proximal end 38 a of the tube 38 upto the distal end 38 b of the tube 38. The tube 38 is provided at itsproximal end 38 a with an asymmetrical outer flange 40, said outerflange 40 being provided on its proximal face with an inclined surface41, of the same shape as the inclined surface 34 described for tube 32of FIG. 10. In consequence, as can be seen on FIG. 12, the flange 40 isthicker in its part being in alignment with the longitudinal cut 39.

With reference to FIG. 13, the outer wall of the tube 38 is providedwith a cam 42 diametrically opposing the longitudinal cut 39. The cam 42comprises a first longitudinal track 43 and a second longitudinal track44 substantially parallel to each other and separated by a separationwall 45. The first and second longitudinal tracks (43, 44) are joined attheir respective proximal ends via an intersection 46. In the vicinityof the intersection 46, the first longitudinal track 43 is provided witha ramp 47, the distal end of which is provided with an inclined surface48, the inclined surface 48 facing the second longitudinal track 44. Inaddition, the first longitudinal track 43 is provided with a step 49,located distally with respect to said ramp 47. The second longitudinaltrack 44 extends distally until the distal end 38 b of the tube 38.

As will appear clearly from the description of FIGS. 12-16, the needleshield 36 is axially movable with respect to the tube 38 between a“before use” position, in which said needle shield 36 leaves a “beforeuse” portion of the needle 3 uncovered, the needle 3 being visible bythe user as shown on FIG. 12, an “in use” position in which said needleshield 36 leaves a “in use” portion of said needle 3 uncovered, the “inuse” position being greater than the “before use” portion, as shown onFIG. 14, and an “after use” position in which said needle shield 36covers said needle 3, as shown on FIGS. 15 and 16.

With reference to FIG. 12, in the “before use” position of the needleshield 36, the tube 38 is received within the needle shield 36 and theproximal face 38 a of the tube 38 bears on the distal plane surface 7defined by the rim 6 of the support 2 by means of the thicker part ofthe outer flange 40 bearing on the distal surface 7 of the rim 6 of thesupport 2. As appears also from FIG. 1, in this position, the tube 38 ismaintained coaxial with the needle shield 36 because it is surrounded bythe needle shield 36 which is tubular. In consequence, the respectivelongitudinal axis A′ and B′ of the needle shield 36 and of the tube 38are merged. Part of the inclined surface 41 of the outer flange 40 whichis diametrically opposed to the thicker part does not contact the distalplane surface 7 of the rim 6 as is shown on FIG. 12. As a remark, onthis figure, the longitudinal axis A′ and B′ are also merged with thelongitudinal axis of the injection device 100. In other words, theneedle shield 36 and the tube 38 are in alignment with each other.

With reference to FIG. 12, the needle protection assembly 1 of FIG. 12further comprises an outer sleeve 50 which receives the needle shield36. The outer sleeve 50 is fixed to the barrel 25.

The needle protection assembly 1 of FIG. 12 further comprises a helicalspring 51, located between the needle shield 36 and the tube 38. On theexample shown on FIG. 12, the proximal end of the helical spring 51bears on the distal face of the outer flange 40 of the tube 38 and itsdistal end bears on the proximal end 36 a of the needle shield 36. Inthe “before use” position shown on FIG. 12, the helical spring 51 is ina partially expanded state. As will appear later in the detaileddescription of the operation of the injection device 100, the helicalspring 51 acts as urging means for displacing the needle shield 36 fromits “in use” position to its “after use” position.

The operation of the needle protection assembly 1 and of the injectiondevice 100 will now be explained in reference to FIGS. 12 to 16.

On FIG. 12, the needle protection assembly 1 is in a “before use”position, the needle shield 8 covers part of the needle 3. Therefore,the needle 3 is visible for the user. The user can prick the needle 3 inthe site of injection.

In this “before use” position, in reference with FIGS. 12 and 13, thepeg 37 of the needle shield 36 is in an initial position located betweenthe ramp 47 and the step 49 of the first track 43 of the cam 42 of thetube 38. The distal movement of the peg 37 is therefore prevented by thestep 49.

In this “before use” position shown on FIG. 12, the longitudinal axis A′of the needle shield 36 and the longitudinal axis B′ of the tube 38 aremerged. The needle shield 36 and the tube 38 are in alignment with eachother.

The user then applies the injection device 100 on the skin of a patient(not shown), inserts the needle 3 into the injection site until thedistal end 36 b of the needle shield 36 comes in contact with the skin.In order to fully insert the needle 3 in the site of injection, the userthen exerts a distal pressure on the injection device 100, this havingas a consequence to cause the distal movement of the outer sleeve 50with respect to the needle shield 36, as shown on FIG. 14, said needleshield 36 being blocked against the skin of the patient (not shown).During the distal movement of the outer sleeve 50, the support 2, whichis fixed to the outer sleeve 50, has also moved distally and has pushedthe tube 38 in the distal direction via the rim 6 contacting the thickerpart of the outer flange 40 of the tube 38. The needle shield 36 beingstopped against the skin of the patient, the helical spring 51 is now ina more compressed state than in the before use position, as shown onFIG. 4. During the distal movement of the tube 38 with respect to theneedle shield 36, the peg 37 has overcome the ramp 47 (see FIG. 13) andis now in abutment against the distal face of the intersection 46 of thefirst and second longitudinal tracks (43, 44) of the cam 42. The needleshield 36 is now in its “in use” position. The user may then realize theinjection of the product to be injected.

in this “in use” position of the needle shield 36 as shown on FIG. 14,the longitudinal axis A′ of the needle shield 36 and the longitudinalaxis B′ of the tube 38 are merged. The needle shield 36 and the tube 38are in alignment with each other.

Once the injection step (not shown) is completed, the user releases itsdistal pressure on the injection device 100 and removes the injectiondevice 100 from the injection site and the needle shield 36 is no moreblocked by the skin of the patient. The helical spring 51 is thereforefree to return to its expanded state and it causes the distal movementof the needle shield 36 with respect to the support 2 and to the tube 38as shown on FIG. 15.

In reference with FIG. 13, the peg 37 (not shown) of the needle shield36 is guided into the second track 44 of the cam 42 by the inclinedsurface 48. The peg 37 then travels all along the second longitudinaltrack 44 and escapes the second longitudinal track 44 together with thetube 38, as shown on FIG. 15, until it reaches it final position,corresponding to the “after use” position of the needle shield 36. Asappears from FIG. 15, the final position of the peg 37 is thereforedistally spaced with respect to its initial position.

The needle shield 36 therefore deploys and covers the needle 3, therebypreventing any accidental needle stick injury for the user and anyre-use of the injection device 100. During this step, the helical spring51 acts as urging means tending to displace the needle shield 36 fromits “in use” position to its “after use” position.

While expanding, the helical spring 51 has pushed the needle shield 36distally beyond the tube 38 which is then no more surrounded by theneedle shield 36, as shown on FIG. 15, at the moment the needle shield36 reaches its “after use” position”. In consequence, the tube 38 is nomore maintained coaxial with the needle shield 36. Thanks to thelongitudinal cut 39 and to the inclined surface 41 of the outer flange40 tending to be in tighter contact with the distal plane surface 7 ofthe rim of the support 2, the tube 38 naturally cants, as shown on FIG.16 and its distal end 38 b comes in regard to the proximal end 36 a ofthe needle shield 36. The tube 38 is no more coaxial with the needleshield 36. This can be seen on FIG. 16 on which the longitudinal axis A′of the needle shield 36 and the longitudinal axis B′ of the tube 38intersect and are now forming an angle α′. The tube 38 therefore acts asa locking element of the needle shield 36 and is in a “locking position”when the needle shield 36 is in its “after use” position. As is visiblefrom FIGS. 12 and 14, in the “before use” and “in use” positions of theneedle shield 36, the tube 38 remained coaxial with the needle shield 36and did not prevent movement of said needle shield 36 from a position tothe other. On these FIGS. 12 and 14, the locking element formed by thetube 38 was in a “free position”.

In all embodiments of the needle protection assembly of the inventiondescribed hereinabove, the locking element is not formed by thecooperation of the peg and the cam: this allows the urging means, usedto cause the distal movement of the needle shield at the end ofinjection, to be low duty and not to have too high a force, thereforeavoiding deformation of parts forming the needle protection assembly.

What is claimed is:
 1. A needle protection assembly, comprising: asupport at least partially supporting a needle; a needle shield moveablerelative to the support from a first position in which at least aportion of the needle is exposed, to a second position in which theneedle is fully shielded; and a locking element disposed at leastpartially within the support, the locking element having an asymmetricalouter flange located at a proximal end thereof, a longitudinal cut beingformed in a distal end of the locking element which extends proximallytherefrom, wherein, with the needle shield in the second position, thelocking element is skewed to inhibit movement of the needle shield fromthe second position to the first position.
 2. The needle protectionassembly of claim 1, wherein the asymmetrical outer flange comprises athickened portion in alignment with the longitudinal cut.
 3. The needleprotection assembly of claim 1, wherein the locking element has the formof a tube.
 4. The needle protection assembly of claim 1, wherein theneedle shield extends further from the support in the second position ascompared to the first position.
 5. The needle protection assembly ofclaim 1, further comprising a peg provided on one of the support and theneedle shield, and a cam provided on the other of the support and theneedle shield, the peg being moveable within the cam during transitionfrom the first position to the second position.
 6. The needle protectionassembly of claim 5, wherein the locking element is separate from thepeg and the cam.
 7. The needle protection assembly of claim 1, whereinthe needle shield defines a longitudinal axis and the locking elementdefines a longitudinal axis, wherein the longitudinal axis of the needleshield and the longitudinal axis of the locking element are aligned whenthe needle shield is in the first position, and the longitudinal axis ofthe needle shield forms an acute angle with respect to the longitudinalaxis of the locking element when the needle shield is in the secondposition.
 8. The needle protection assembly of claim 1, furthercomprising a spring for biasing the needle shield from the firstposition to the second position.
 9. A needle protection assembly,comprising: a support at least partially supporting a needle; a needleshield moveable relative to the support from a first position to asecond position, wherein the needle shield extends further from thesupport in the second position as compared to the first position; a pegprovided on one of the support and the needle shield; and a cam providedon the other of the support and the needle shield, the peg beingmoveable within the cam during transition from the first position to thesecond position, the cam comprising first and second tracks joining atan intersection via their ends, wherein the peg is located at a firstposition in the first track when the needle shield is in the firstposition, and the peg is located at a second position in the secondtrack when the needle shield is in the second position, and wherein thesecond position is axially spaced with respect to the first position.10. The needle protection assembly of claim 9, wherein the first trackand the second track each define a generally longitudinal profile. 11.The needle protection assembly of claim 9, wherein the first position ofthe needle shield is an “in use” position, and in the “in use” positionan “in use” portion of the needle is exposed, and the second position ofthe needle shield is an “after use” position and in the “after use”position, the needle shield covers the needle.
 12. The needle protectionassembly of claim 11, wherein the needle shield is further moveablebetween a “before use” position and the “in use” position, wherein inthe “before use” position a “before use” portion of the needle isexposed, the “in use” portion being greater than the “before use”portion.
 13. The needle protection assembly of claim 12, wherein the camis located at the intersection when the needle shield is in the “in useposition”.
 14. The needle protection assembly of claim 11, wherein thecam further comprises an inclined surface at the intersection of thefirst and second tracks, the inclined surface advancing the peg into thesecond track when the needle shield moves from the “in use” position tothe “after use” position.